Momenta Pharmaceuticals, Inc. - News/Events - Press Releases

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004

11/06/2007

Momenta Pharmaceuticals Announces Receipt of FDA Letter -- M-Enoxaparin ANDA Not Approvable in Current Form

11/01/2007

Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2007

10/31/2007

Momenta Pharmaceuticals to Present at 9th Annual MASS Opportunities Investment Conference

10/30/2007

Momenta Pharmaceuticals Announces Appointment of Elizabeth Stoner, M.D. to Board of Directors

10/26/2007

Momenta Pharmaceuticals to Present at Upcoming Healthcare Conferences

10/25/2007

Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources

10/24/2007

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2007 Financial Results

10/11/2007

Momenta Pharmaceuticals Initiates Phase 2 Study of Novel Anticoagulant M118

10/08/2007

Momenta Pharmaceuticals to Present at the BIO Investor Forum

09/27/2007

Momenta Pharmaceuticals Announces Executive Promotions

09/05/2007

Momenta Pharmaceuticals to Present At the Bear Stearns 20th Annual Healthcare Conference

08/07/2007

Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2007

07/13/2007

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2007 Financial Results

06/11/2007

Momenta Pharmaceuticals to Present At the Sixth Annual Needham Biotechnology & Medical Technology Conference

05/23/2007

Momenta Pharmaceuticals to Present At the Bank of America Health Care Conference

05/18/2007

Momenta Pharmaceuticals to Present At the Citigroup 2007 Healthcare Conference

05/16/2007

Momenta Pharmaceuticals Announces Date for 2007 Annual Meeting of Stockholders

05/14/2007

Momenta Pharmaceuticals to Present At the Acumen BioFion Rodman & Renshaw 4th Annual Global Healthcare Conference

05/14/2007

Momenta Pharmaceuticals Initiates Phase I Clinical Study for M118 Subcutaneous Formulation

05/08/2007

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2007

04/24/2007

Momenta Pharmaceuticals to Present At the Morgan Stanley Global Healthcare Unplugged Conference

04/24/2007

Momenta Pharmaceuticals to Present At the Deutsche Bank - 32nd Annual Health Care Conference

04/18/2007

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2007 Financial Results

04/05/2007

Momenta Pharmaceuticals to Present At the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference

03/26/2007

Momenta Pharmaceuticals Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology

03/08/2007

Momenta Pharmaceuticals to Present At the Cowen and Company 27th Annual Health Care Conference

02/13/2007

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter of 2006 and Announces 2007 Goals

02/06/2007

Momenta Pharmaceuticals to Present At BIO CEO & Investor Conference 2007

01/23/2007

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter 2006 Financial Results